Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
Int J Mol Sci ; 24(23)2023 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-38069362

RESUMO

Consistent with well-established biochemical properties of coronaviruses, sialylated glycan attachments between SARS-CoV-2 spike protein (SP) and host cells are key to the virus's pathology. SARS-CoV-2 SP attaches to and aggregates red blood cells (RBCs), as shown in many pre-clinical and clinical studies, causing pulmonary and extrapulmonary microthrombi and hypoxia in severe COVID-19 patients. SARS-CoV-2 SP attachments to the heavily sialylated surfaces of platelets (which, like RBCs, have no ACE2) and endothelial cells (having minimal ACE2) compound this vascular damage. Notably, experimentally induced RBC aggregation in vivo causes the same key morbidities as for severe COVID-19, including microvascular occlusion, blood clots, hypoxia and myocarditis. Key risk factors for COVID-19 morbidity, including older age, diabetes and obesity, are all characterized by markedly increased propensity to RBC clumping. For mammalian species, the degree of clinical susceptibility to COVID-19 correlates to RBC aggregability with p = 0.033. Notably, of the five human betacoronaviruses, the two common cold strains express an enzyme that releases glycan attachments, while the deadly SARS, SARS-CoV-2 and MERS do not, although viral loads for COVID-19 and the two common cold infections are similar. These biochemical insights also explain the previously puzzling clinical efficacy of certain generics against COVID-19 and may support the development of future therapeutic strategies for COVID-19 and long COVID patients.


Assuntos
COVID-19 , Resfriado Comum , Animais , Humanos , Glicoproteína da Espícula de Coronavírus/metabolismo , SARS-CoV-2/metabolismo , Síndrome de COVID-19 Pós-Aguda , Células Endoteliais/metabolismo , Enzima de Conversão de Angiotensina 2/metabolismo , Polissacarídeos/metabolismo , Morbidade , Hipóxia , Mamíferos/metabolismo
2.
Int J Mol Sci ; 24(14)2023 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-37511206

RESUMO

Hypercoagulability and formation of extensive and difficult-to-lyse microclots are a hallmark of both acute COVID-19 and long COVID. Fibrinogen, when converted to fibrin, is responsible for clot formation, but abnormal structural and mechanical clot properties can lead to pathologic thrombosis. Recent experimental evidence suggests that the spike protein (SP) from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may directly bind to the blood coagulation factor fibrinogen and induce structurally abnormal blood clots with heightened proinflammatory activity. Accordingly, in this study, we used molecular docking and molecular dynamics simulations to explore the potential activity of the antiparasitic drug ivermectin (IVM) to prevent the binding of the SARS-CoV-2 SP to fibrinogen and reduce the occurrence of microclots. Our computational results indicate that IVM may bind with high affinity to multiple sites on the fibrinogen peptide, with binding more likely in the central, E region, and in the coiled-coil region, as opposed to the globular D region. Taken together, our in silico results suggest that IVM may interfere with SP-fibrinogen binding and, potentially, decrease the formation of fibrin clots resistant to degradation. Additional in vitro studies are warranted to validate whether IVM binding to fibrinogen is sufficiently stable to prevent interaction with the SP, and potentially reduce its thrombo-inflammatory effect in vivo.


Assuntos
COVID-19 , Fibrinogênio , Ivermectina , Trombose , Humanos , Fibrina/metabolismo , Fibrinogênio/metabolismo , Hemostáticos , Ivermectina/farmacologia , Ivermectina/uso terapêutico , Simulação de Acoplamento Molecular , Síndrome de COVID-19 Pós-Aguda , SARS-CoV-2/metabolismo , Trombose/metabolismo
3.
J Mol Graph Model ; 126: 108670, 2024 01.
Artigo em Inglês | MEDLINE | ID: mdl-37984193

RESUMO

Protein-protein interaction occurs on surface patches with some degree of complementary geometric and chemical features. Building on this understanding, this study endeavors to characterize the spike protein of the SARS-CoV-2 virus at the morphological and geometrical levels in its Alpha, Delta, and Omicron variants. In particular, the affinity between different SARS-CoV-2 spike proteins and the ACE2 receptor present on the membrane of the human respiratory system cells is investigated. To achieve an adequate degree of geometrical accuracy, the 3D depth maps of the proteins in exam are filtered by developing an ad-hoc convolutional filter with a kernel implemented as a sphere of varying radius, simulating a ball rolling on the surface (similar to the 'rolling ball' filter). This ball ideally models a hypothetical molecule that could interface with the protein and is inspired by the geometric approach to macromolecule-ligand interactions proposed by Kuntz et al. in 1982. The aim is to mitigate the imperfections and to obtain a smoother surface that could be studied from a geometrical perspective for binding purposes. A set of geometric descriptors, borrowed from the 3D face analysis context is then mapped point-by-point onto protein depth maps. Following a feature extraction phase inspired by Histogram of Oriented Gradients and Local Binary Patterns, the final histogram features are used as input for a Support Vector Machine classifier to automatically classify the proteins according to their surface affinity, where a similarity in shape is observed between ACE2 and the spike protein of the SARS-CoV-2 Omicron variant. Finally, Root Mean Square Error analysis is used to quantify the geometrical affinity between the ACE2 receptor and the respective Receptor Binding Domains of the three SARS-CoV-2 variants, culminating in a geometrical explanation for the higher contagiousness of Omicron relative to the other variants under study.


Assuntos
COVID-19 , Humanos , SARS-CoV-2 , Enzima de Conversão de Angiotensina 2 , Glicoproteína da Espícula de Coronavírus , Ligação Proteica , Mutação
4.
Cancers (Basel) ; 15(6)2023 Mar 10.
Artigo em Inglês | MEDLINE | ID: mdl-36980600

RESUMO

Given its critical role in cell mitosis, the tubulin γ chain represents a viable chemotherapeutic target to solve the specificity issues associated with targeting α and ß tubulin. Since γ tubulin is overexpressed in glioblastoma multiforme (GBM) and some breast lesions, the glaziovianin A derivative gatastatin, presented as a γ-tubulin-specific inhibitor, could yield a successful therapeutic strategy. The present work aims to identify the binding sites and modes of gatastatin and its derivatives through molecular-docking simulations. Computational binding free energy predictions were compared to experimental microscale thermophoresis assay results. The computational simulations did not reveal a strong preference toward γ tubulin, suggesting that further derivatization may be needed to increase its specificity.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA